The Therapeutic Effects of Peroneal Nerve Functional Electrical Stimulation for Lower Extremity in Patients With Sub-acute Post-stroke Hemiplegia (RALLY)
The Therapeutic Effects of Peroneal Nerve Functional Electrical Stimulation for Lower Extremity in Patients With Sub-acute Post-stroke Hemiplegia A Randomized Controlled Study
Among the sequelae of stroke, gait disorder is directly linked to the degree of autonomy in the daily life of patients. It is considered significant effects on their Quality of Life(QOL).
Further methods of rehabilitation are required for convalescent patients to recover their function soon and better, due to a multitudes of recovery patient with troubles such as gait problem.
This trial is studying to investigate the effects of gait training with a functional electrical stimulation (FES) 'WalkAide[R](WA)' to improve the lower-limb function and ambulation in convalescent stroke patients.
研究概览
详细说明
This study is targeting convalescent patients within 6 months after the onset of initial stroke (cerebral infarction or cerebral hemorrhage) and also observing the foot drop during walking.
Some study for the patients after the onset of stroke (over several months) are reported that a case of the efficacy by the treatment using the FES, and another case of using FES indicated the equal efficacy and the higher QOL compared to using ankle-foot orthosis(AFO).
However, these are clinical research results overseas and there are not so many studies targeting only for convalescent stroke patients.
FES which recover the lost function by paralysis using electrical stimulation is recommended as convalescent rehabilitation by Japanese Guidelines for the Management of Stroke 2015 etc..
The purpose of FES treatment is the electrical stimulation to peroneal nerve of patients with foot drop and equinus foot due to central nervous system damage and the objective efficacy is following:
- To improve the walking by dorsiflexing the foot during swing phase
- To prevention and suppression of disuse atrophy
- To increase local blood flow
- To re-educate muscle
- To maintain or increase the range of joint motion
研究类型
注册 (实际的)
阶段
- 不适用
联系人和位置
学习地点
-
-
Chiba-prefecture
-
Yachiyo-city、Chiba-prefecture、日本、276-0015
- Shinyachiyo Hospital
-
-
Ehime-prefecture
-
Matsuyama-city、Ehime-prefecture、日本、791-1111
- Matsuyama Rehabilitation Hospital
-
-
Fukuoka-prefecture
-
Kurume-city、Fukuoka-prefecture、日本、830-0047
- St.Mary's Hospital Healthcare Center
-
Yame-city、Fukuoka-prefecture、日本、834-0006
- Yame Rehabilitation Hospital
-
-
Hokkaido-prefecture
-
Kitami-city、Hokkaido-prefecture、日本、090-0837
- Hokusei Memorial Hospital
-
Muroran-city、Hokkaido-prefecture、日本、050-0082
- Ohkawara Neurosurgical Hospital
-
Obihiro-city、Hokkaido-prefecture、日本、080-0833
- Tokachi Rehabilitation Center
-
Sapporo-city、Hokkaido-prefecture、日本、003-0026
- Sapporo Shiroishi Memorial Hospital
-
Sapporo-city、Hokkaido-prefecture、日本、060-0031
- Tokeidai Memorial Hospital
-
Sapporo-city、Hokkaido-prefecture、日本、060-0010
- Sapporo Keijinkai Rehabilitation Hospital
-
-
Hyogo-prefecture
-
Kobe-city、Hyogo-prefecture、日本、652-0803
- Yoshida Hospital, Cerebrovascular Research Institute
-
-
Kagoshima-prefecture
-
Aira-city、Kagoshima-prefecture、日本、899-5241
- Kajikionsen Hospital
-
Kagoshima-city、Kagoshima-prefecture、日本、890-0031
- Acras Central Hospital
-
Kagoshima-city、Kagoshima-prefecture、日本、890-8520
- Department of Rehabilitation and Physical Medicine, Graduate School of Medical and Dental Sciences, Kagoshima University
-
Kanoya-city、Kagoshima-prefecture、日本、893-0023
- Kohshinkai Ogura Hospital
-
Tarumi-city、Kagoshima-prefecture、日本、891-2124
- Tarumi City Medical Center Tarumi Central Hospital
-
-
Kumamoto-prefecture
-
Kumamoto-city、Kumamoto-prefecture、日本、861-4173
- Sakura Jyuji Hospital
-
Kumamoto-city、Kumamoto-prefecture、日本、862-0924
- Kumamoto Takumadai Rehabilitation Hospital
-
-
Miyazaki-prefecture
-
Miyakonojo-city、Miyazaki-prefecture、日本、885-0072
- Fujimotokanmachi Hospital
-
Miyazaki-city、Miyazaki-prefecture、日本、880-2112
- Junwakai Memorial Hospital
-
Nichinan-city、Miyazaki-prefecture、日本、889-3141
- Nichinan Municipal Chubu Hospital
-
-
Nagasaki-prefecture
-
Sasebo-city、Nagasaki-prefecture、日本、857-0022
- Yohkoh Rehabilitation Hospital
-
Togitsu-cho, Nishisonogi-gun、Nagasaki-prefecture、日本、851-2103
- Nagasakikita Hospital
-
-
Okinawa-prefecture
-
Okinawa-city、Okinawa-prefecture、日本、904-2151
- Chuzan Hospital
-
Okinawa-city、Okinawa-prefecture、日本、904-2173
- Okinawa Rehabilitation Center Hospital
-
Shimajiri-gun、Okinawa-prefecture、日本、901-0493
- Nanbu-Tokushukai Hospital
-
-
Osaka-prefecture
-
Toyonaka-city、Osaka-prefecture、日本、560-0054
- Kansai Rehabilitation Hospital
-
-
Saitama-prefecture
-
Misato-city、Saitama-prefecture、日本、341-0034
- Saitama Misato Sogo Rehabilitation Hospital
-
-
Shizuoka-prefecture
-
Hamamatsu-city、Shizuoka-prefecture、日本、433-8511
- Seirei Hamamatsu City Rehabilitaion Hospital
-
-
Tokyo
-
Adachi-ku、Tokyo、日本、123-0864
- Hakujikai Memorial Hospital
-
Itabashi-ku、Tokyo、日本、174-0051
- IMS Itabashi Rehabilitation Hospital
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- 1) Patients who agree to participate in this study and provide their informed consent
- 2) Patients from 20 to 85 years old at the time of consent
- 3) Patients of convalescent stoke (within 6 months of onset)
- 4) Patients with a first episode of stroke, which type limited intracranial hemorrhage or ischemic stroke (excluding subarachnoid hemorrhage)
- 5) Patients inpatients for the rehabilitation therapy
- 6) Patients diagnosed 3 or 4 on Functional Ambulation Classification (FAC)
- 7) Patients stable general condition(blood pressure, pulse, blood glucose level etc.)
- 8) Patients with drop foot in walking
Exclusion Criteria:
- 1) Patients due to severe heart disease
- 2) Patients with previous gait disability, such as neurological disease
- 3) Patients with previous orthopedic disease, such as knee osteoarthritis
- 4) Patients with severe hepatic or renal dysfunction
- 5) Patients with severe sensory disturbance or severe ataxia or severe higher brain dysfunction
- 6) Patients correspond to contraindicated for the electrical stimulation (e.g. patients with a medical implant or implantable medical electrical equipment such as a cardiac pacemaker)
- 7) Patients with severe skin disease
- 8) Patients with any dose adjustment of antispasticity drugs (tizanidine hydrochloride, eperisone hydrochloride, baclofen, etc.) within 1month
- 9) Patients whose impairment severities changed during the study period
- 10) Patients taking the botulinum toxin formulation injection or the nerve block injection with phenol within 6months
- 11) Patients with any lower limb treatment using FES or the robot suit within 1month
- 12) Patients diagnosed not to use during the the WA trial operation period
- 13) Patients who do not complete the WA trial operation for 7 days
- 14) Patients joining any other clinical trials or studies with intervention
学习计划
研究是如何设计的？
设计细节
- 主要用途：治疗
- 分配：随机化
- 介入模型：并行分配
- 屏蔽：无（打开标签）
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
有源比较器：控制
|
Conventional rehabilitation therapy and gait training without WA.
|
|
实验性的：WA
|
Conventional rehabilitation therapy and gait training with WAIntervention with WA is scheduled 40min/day, five times a week, for 8 weeks.
|
研究衡量的是什么？
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
maximum walking distance of 6 Minute Walk Test (bare feet)
大体时间：8weeks
|
Measuring maximum walking distance of 6 Minute Walk Test at baseline and after 8-weeks intervention.
Calculating difference of those measured values.
Targeting for all patients.
|
8weeks
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
maximum walking distance of 6 Minute Walk Test (with WA)
大体时间：8weeks
|
Measuring maximum walking distance of 6 Minute Walk Test at baseline and after 8-weeks intervention. Calculating difference of those measured values. Targeting only for WA group. |
8weeks
|
|
maximum walking distance of 6 Minute Walk Test (with AFO)
大体时间：8weeks
|
Measuring maximum walking distance of 6 Minute Walk Test at baseline and after 8-weeks intervention. Calculating difference of those measured values. Targeting only for patients using AFO before starting this study. |
8weeks
|
|
walking speed of 10 Meter Walk Test (bare feet)
大体时间：8weeks
|
Measuring maximum walking speed of 10 Meter Walk Test at baseline and after 8-weeks intervention.
Calculating difference of those measured values.
Targeting for all patients.
|
8weeks
|
|
walking speed of 10 Meter Walk Test (with WA)
大体时间：8weeks
|
Measuring maximum walking speed of 10 Meter Walk Test at baseline and after 8-weeks intervention.
Calculating difference of those measured values.
Targeting only for WA group.
|
8weeks
|
|
walking speed of 10 Meter Walk Test (with AFO)
大体时间：8weeks
|
Measuring maximum walking speed of 10 Meter Walk Test at baseline and after 8-weeks intervention.
Calculating difference of those measured values.
Targeting only for patients using AFO before starting this study.
|
8weeks
|
|
Fugl-Meyer assessment (FMA)
大体时间：8weeks
|
Calculating difference of the total score of lower extremity subscale of the Fugl-Meyer Assessment (perfect score: 34 points) at baseline and after 8-weeks intervention.
|
8weeks
|
|
modified Ashworth scale (MAS)
大体时间：8weeks
|
Calculating difference of the muscle tone six levels ( 0 , 1 , 1+ , 2 , 3 , 4 ) at baseline and after 8-weeks intervention.
|
8weeks
|
|
range of motion
大体时间：8weeks
|
Calculating difference of the angle of the ankle succumbed back (5 ° increments) at baseline and after 8-weeks intervention.
|
8weeks
|
|
Timed up and go test (bere feet)
大体时间：8weeks
|
Measuring the time that patients take to rise from a chair, walk three metres, turn around, walk back to the chair, and sit down . Calculating difference of those measured values between at baseline and after 8-weeks intervention. Targeting for all patients. |
8weeks
|
|
Timed up and go test (with AFO)
大体时间：8weeks
|
Measuring the time that patients take to rise from a chair, walk three metres, turn around, walk back to the chair, and sit down . Calculating difference of those measured values between at baseline and after 8-weeks intervention. Targeting only for patients using AFO before starting this study. |
8weeks
|
|
Timed up and go test (with WA)
大体时间：8weeks
|
Measuring the time that patients take to rise from a chair, walk three metres, turn around, walk back to the chair, and sit down . Calculating difference of those measured values between at baseline and after 8-weeks intervention. Targeting only for WA group. |
8weeks
|
|
Stroke Impact Scale (SIS)
大体时间：8weeks
|
An evaluation of summation score of the total score and physical domain (sixth domain) score.
Calculating difference of those measured values between at baseline and after 8-weeks intervention.
|
8weeks
|
|
Patient reported outcome measure (PRO)
大体时间：8weeks
|
Evaluation gait analysis using visual analogue scale(VAS scale) by Patient's own.
Calculating the difference of these VAS scale between at baseline and after 8-weeks intervention.
|
8weeks
|
|
gait analysis by medical staff
大体时间：8weeks
|
Evaluation using total score of gait analysis by medical staff (-48~48).Calculating difference of these score between at baseline and after 8-weeks intervention.
|
8weeks
|
|
Adverse event assessment
大体时间：8weeks
|
A frequency counting of the adverse events. LLT code will be assigned to the reported adverse event using the MedDRA dictionary. The origin date of the term until adverse events define the start date of the treatment program(0 week). Also doing a frequency counting of adverse events observed during the the WA trial operation period, but not included in the safety evaluation of the treatment program. |
8weeks
|
合作者和调查者
调查人员
- 学习椅：Shuji Matsumoto, MD, Ph.D、Nippon Medical School
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.